Parkinson's Disease Medication Administration During a Care Transition: The Impact of Interprofessional Team Simulation on Student Competency, Comfort, and Knowledge.
Document Type
Article
Publication Date
12-21-2021
Abstract
AIM: This study investigated the impact of an interprofessional mock code on students' comfort and competency related to Parkinson's disease (PD) medication administration during care transitions.
BACKGROUD: Patients with PD are at increased risk for medication errors during hospitalization. Individualization of PD medication creates vulnerability during care transitions.
METHOD: Four interprofessional groups took part in this study: baccalaureate degree senior nursing students (n = 113), master's level nurse anesthesia students (n = 35), doctor of osteopathic medicine fourth-year students (n = 32), and doctor of clinical psychology fourth-year students (n = 22). Groups participated in an unfolding case study simulation involving a mock code with a focus on the omission of time-sensitive PD medication. Pre- and postsimulation test results were compared.
RESULTS: Findings indicated an increased understanding among three of the four groups relating to medication timing during care transitions.
CONCLUSION: All groups improved with respect to perceived comfort and competency.
Publication Title
Nursing Education Perspectives
PubMed ID
34974503
Recommended Citation
Ellis, Diane M; Hickey, Shelley; Prieto, Patricia; McLaughlin, Carlene; Felgoise, Stephanie H.; Becker, Michael; O'Connor, Melissa; Puleo, Madison; Reddy, Tara; Markey, Danielle; Kim, Lydia; and Bernhardt, Paul W, "Parkinson's Disease Medication Administration During a Care Transition: The Impact of Interprofessional Team Simulation on Student Competency, Comfort, and Knowledge." (2021). PCOM Scholarly Works. 2139.
https://digitalcommons.pcom.edu/scholarly_papers/2139
Comments
This article was published in Nursing Education Perspectives.
The published version is available at https://doi.org/10.1097/01.nep.0000000000000920.
Copyright © 2021 Lippincott Williams & Wilkins, Inc.